vs
FVCBankcorp, Inc.（FVCB）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
FVCBankcorp, Inc.的季度营收约是礼来的1.4倍（$16.9M vs $12.5M），FVCBankcorp, Inc.同比增速更快（4377.5% vs 434.0%），FVCBankcorp, Inc.自由现金流更多（$23.8M vs $-156.9M），过去两年FVCBankcorp, Inc.的营收复合增速更高（586.6% vs 138.5%）
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司，旗下运营社区银行FVCbank，面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
FVCB vs RNA — 直观对比
营收规模更大
FVCB
是对方的1.4倍
$12.5M
营收增速更快
FVCB
高出3943.5%
434.0%
自由现金流更多
FVCB
多$180.7M
$-156.9M
两年增速更快
FVCB
近两年复合增速
138.5%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.9M | $12.5M |
| 净利润 | — | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | 43.7% | -1513.5% |
| 净利率 | — | -1398.3% |
| 营收同比 | 4377.5% | 434.0% |
| 净利润同比 | — | -117.0% |
| 每股收益（稀释后） | $0.31 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVCBRNA
| Q4 25 | $16.9M | — | ||
| Q3 25 | $416.0K | $12.5M | ||
| Q2 25 | $15.8M | $3.8M | ||
| Q1 25 | $382.0K | $1.6M | ||
| Q4 24 | $378.0K | $3.0M | ||
| Q3 24 | $412.0K | $2.3M | ||
| Q2 24 | $415.0K | $2.0M | ||
| Q1 24 | $359.0K | $3.5M |
净利润FVCBRNA
| Q4 25 | — | — | ||
| Q3 25 | $5.6M | $-174.4M | ||
| Q2 25 | $5.7M | $-157.3M | ||
| Q1 25 | $5.2M | $-115.8M | ||
| Q4 24 | — | $-102.3M | ||
| Q3 24 | $4.7M | $-80.4M | ||
| Q2 24 | $4.2M | $-70.8M | ||
| Q1 24 | $1.3M | $-68.9M |
营业利润率FVCBRNA
| Q4 25 | 43.7% | — | ||
| Q3 25 | — | -1513.5% | ||
| Q2 25 | 45.9% | -4448.7% | ||
| Q1 25 | — | -8360.9% | ||
| Q4 24 | — | -4069.6% | ||
| Q3 24 | — | -4200.9% | ||
| Q2 24 | — | -4040.4% | ||
| Q1 24 | — | -2178.6% |
净利率FVCBRNA
| Q4 25 | — | — | ||
| Q3 25 | 1341.1% | -1398.3% | ||
| Q2 25 | 36.0% | -4089.3% | ||
| Q1 25 | 1352.1% | -7360.0% | ||
| Q4 24 | — | -3439.5% | ||
| Q3 24 | 1133.3% | -3441.7% | ||
| Q2 24 | 1001.2% | -3461.8% | ||
| Q1 24 | 373.3% | -1943.4% |
每股收益（稀释后）FVCBRNA
| Q4 25 | $0.31 | — | ||
| Q3 25 | $0.31 | $-1.27 | ||
| Q2 25 | $0.31 | $-1.21 | ||
| Q1 25 | $0.28 | $-0.90 | ||
| Q4 24 | $0.27 | $-0.80 | ||
| Q3 24 | $0.25 | $-0.65 | ||
| Q2 24 | $0.23 | $-0.65 | ||
| Q1 24 | $0.07 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $253.6M | $1.9B |
| 总资产 | $2.3B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FVCBRNA
| Q4 25 | — | — | ||
| Q3 25 | — | $350.2M | ||
| Q2 25 | — | $243.9M | ||
| Q1 25 | — | $254.2M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | — | $370.2M | ||
| Q2 24 | — | $575.8M | ||
| Q1 24 | — | $471.4M |
股东权益FVCBRNA
| Q4 25 | $253.6M | — | ||
| Q3 25 | $249.8M | $1.9B | ||
| Q2 25 | $243.2M | $1.2B | ||
| Q1 25 | $242.3M | $1.3B | ||
| Q4 24 | $235.4M | $1.4B | ||
| Q3 24 | $230.8M | $1.5B | ||
| Q2 24 | $226.5M | $1.2B | ||
| Q1 24 | $220.7M | $830.9M |
总资产FVCBRNA
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.2B | $1.4B | ||
| Q1 25 | $2.2B | $1.5B | ||
| Q4 24 | $2.2B | $1.6B | ||
| Q3 24 | $2.3B | $1.6B | ||
| Q2 24 | $2.3B | $1.3B | ||
| Q1 24 | $2.2B | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.9M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $23.8M | $-156.9M |
| 自由现金流率自由现金流/营收 | 140.7% | -1257.6% |
| 资本支出强度资本支出/营收 | 0.3% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.0M | $-592.3M |
8季度趋势，按日历期对齐
经营现金流FVCBRNA
| Q4 25 | $23.9M | — | ||
| Q3 25 | $7.6M | $-156.2M | ||
| Q2 25 | $3.3M | $-199.7M | ||
| Q1 25 | $5.4M | $-124.8M | ||
| Q4 24 | $18.2M | $-99.9M | ||
| Q3 24 | $4.7M | $-65.6M | ||
| Q2 24 | $1.6M | $-65.0M | ||
| Q1 24 | $7.2M | $-70.4M |
自由现金流FVCBRNA
| Q4 25 | $23.8M | — | ||
| Q3 25 | $7.6M | $-156.9M | ||
| Q2 25 | $3.3M | $-203.0M | ||
| Q1 25 | $5.4M | $-128.6M | ||
| Q4 24 | $18.1M | $-103.8M | ||
| Q3 24 | $4.6M | $-67.3M | ||
| Q2 24 | $1.5M | $-65.5M | ||
| Q1 24 | $7.1M | $-71.3M |
自由现金流率FVCBRNA
| Q4 25 | 140.7% | — | ||
| Q3 25 | 1818.0% | -1257.6% | ||
| Q2 25 | 20.8% | -5277.1% | ||
| Q1 25 | 1413.6% | -8174.3% | ||
| Q4 24 | 4786.0% | -3491.0% | ||
| Q3 24 | 1121.8% | -2881.8% | ||
| Q2 24 | 361.2% | -3204.6% | ||
| Q1 24 | 1988.3% | -2012.3% |
资本支出强度FVCBRNA
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.2% | 5.7% | ||
| Q2 25 | 0.1% | 86.9% | ||
| Q1 25 | 4.2% | 238.6% | ||
| Q4 24 | 37.3% | 131.7% | ||
| Q3 24 | 14.1% | 72.9% | ||
| Q2 24 | 12.8% | 26.0% | ||
| Q1 24 | 3.9% | 25.8% |
现金转化率FVCBRNA
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
